Literature DB >> 19033734

Clinical, anamnestic and serological features of peach allergy in portugal.

Rodrigo Rodrigues-Alves1, Anabela Lopez, Maria Conceição Pereira-Santos, Susana Lopes-Silva, Amélia Spínola-Santos, Célia Costa, Manuel Branco-Ferreira, Jonas Lidholm, Manuel Pereira-Barbosa.   

Abstract

BACKGROUND: Peach is a common food allergen source throughout Europe. The aim of this study was to characterize peach allergy in a Portuguese patient population.
METHODS: Thirty peach-allergic patients confirmed by double-blind placebo-controlled food challenges and 29 controls were included. All subjects completed a standardized questionnaire regarding symptoms and epidemiologic characteristics, skin prick tests with inhalant allergens and foods as well as specific IgE antibodies to peach, recombinant peach allergens rPru p 1, rPru p 3, rPru p 4 and cross-reactive carbohydrate determinants.
RESULTS: Thirty-seven percent of patients reported only oral allergy syndrome, while 37% reported generalized urticaria and/or angioedema, 17% localized contact urticaria and 10% anaphylaxis with peach. Sensitization to other Rosaceae fruits and tree nuts was present in 90 and 77% of the patients, respectively. Respiratory allergy history was associated with less severe symptoms (oral allergy syndrome or contact urticaria; p < 0.01) and positive skin prick test to peach peel or plum with more severe symptoms (urticaria and/or angioedema or anaphylaxis; p < 0.05). Ninety-seven percent were sensitized to Pru p 3, 13% to Pru p 4, 3% to Pru p 1 and 10% to cross-reactive carbohydrate determinants. Pru p 3 specific IgE was associated with Artemisia vulgaris sensitization and tree nut allergy (p < 0.05) but not with clinical severity.
CONCLUSIONS: Half the patients reported systemic reactions to peach. Peach allergy appeared predominantly mediated by Pru p 3 but some patients were sensitized to Pru p 4. Applying a 0.10 kU(A)/l cutoff level, the diagnostic value of combining the 3 recombinant allergens was noteworthy, with 100% sensitivity and 90% specificity. 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19033734     DOI: 10.1159/000176308

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

Review 1.  Overview of component resolved diagnostics.

Authors:  Regina Treudler; Jan C Simon
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

Review 2.  Identification of european allergy patterns to the allergen families PR-10, LTP, and profilin from Rosaceae fruits.

Authors:  Maj-Britt Schmidt Andersen; Sharon Hall; Lars Ove Dragsted
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

3.  Non-specific lipid-transfer proteins: Allergen structure and function, cross-reactivity, sensitization, and epidemiology.

Authors:  Isabel J Skypala; Ricardo Asero; Domingo Barber; Lorenzo Cecchi; Arazeli Diaz Perales; Karin Hoffmann-Sommergruber; Elide A Pastorello; Ines Swoboda; Joan Bartra; Didier G Ebo; Margaretha A Faber; Montserrat Fernández-Rivas; Francesca Gomez; Anastasios P Konstantinopoulos; Olga Luengo; Ronald van Ree; Enrico Scala; Stephen J Till
Journal:  Clin Transl Allergy       Date:  2021-05-18       Impact factor: 5.871

4.  Difficult management of a patient with pr10 related anaphylaxis.

Authors:  Eleonora Nucera; Arianna Aruanno; Alessandro Buonomo; Simona Mezzacappa; Angela Rizzi; Domenico Schiavino
Journal:  Postepy Dermatol Alergol       Date:  2016-10-21       Impact factor: 1.837

Review 5.  Molecular approach to a patient's tailored diagnosis of the oral allergy syndrome.

Authors:  Claudia Alessandri; Rosetta Ferrara; Maria Livia Bernardi; Danila Zennaro; Lisa Tuppo; Ivana Giangrieco; Teresa Ricciardi; Maurizio Tamburrini; Maria Antonietta Ciardiello; Adriano Mari
Journal:  Clin Transl Allergy       Date:  2020-06-17       Impact factor: 5.871

6.  Specific sublingual immunotherapy with peach LTP (Pru p 3). One year treatment: a case report.

Authors:  Celso Pereira; Borja Bartolomé; Juan Andrés Asturias; Iñaki Ibarrola; Beatriz Tavares; Graça Loureiro; Daniel Machado; Celso Chieira
Journal:  Cases J       Date:  2009-05-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.